Posts Tagged ‘daratumumab’

Daratumumab for Myeloma

Posted by • October 6th, 2016

The incorporation of proteasome inhibitors and immunomodulatory drugs into the standard of care has improved outcomes in patients with multiple myeloma over the past 10 years, but most patients still eventually have a relapse. In the October 6, 2016, issue of the New England Journal of Medicine, Dimopoulos et al. report the results of a… Read More…